ASCO 2018: Dr. Bekaii-Saab Highlights Pancreatic Cancer Abstracts

Copy of Dr. Bekaii-Saab on Adjuvant Therapy in Pancreatic CancerПодробнее

Dr. Bekaii-Saab on Adjuvant Therapy in Pancreatic CancerПодробнее

Dr. Bekaii-Saab on Napabucasin in Patients With Pancreatic CancerПодробнее

Dr. Bekaii-Saab Discusses the Evolution of Treatment for Pancreatic CancerПодробнее

ASCO 2018 RECAP :: June 2018 WebinarПодробнее

Dr. Bekaii-Saab on Napabucasin Plus Nab-paclitaxel in Pancreatic CancerПодробнее

Living Room Series June 2018: Highlights from ASCOПодробнее

ICAHO20 - ASCO Direct™ Highlights - Dr. Andrew Coveler - Pancreatic CancerПодробнее

Dr. Bekaii-Saab on Immunotherapy and Viral Therapy for Pancreatic CancerПодробнее

Special Edition ASCO 2021 Highlights RoundTable DiscussionПодробнее

Dr. Bekaii-Saab Discusses PEGPH20 in Pancreatic AdenocarcinomaПодробнее

ASCO GI 2019: Neoadjuvant Chemotherapy Versus Upfront Surgery in Resectable Pancreatic CancerПодробнее

ASCO 2018 Overview: Luciano Costa, MDПодробнее

ASCO: Trial compares common adjuvant treatments for pancreatic cancerПодробнее

What are the symptoms of colorectal cancer? - Dr. Tanios Bekaii-SaabПодробнее

Dr. Bekaii-Saab on the Potential Impact of Napabucasin Combo in Pancreatic CancerПодробнее

My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & Mesothelioma (BMIC-037)Подробнее

Dr. Bekaii-Saab on the APACT Trial in Pancreatic CancerПодробнее

Pancreatic cancer survival extended by over a year with chemotherapy regimenПодробнее